by editor | Jun 3, 2016 | Clinicians, Researchers
Researchers cite ASPREE to inform aspirin guidelines in older adults International researchers anticipate findings from the ASPREE study will help fill a knowledge gap that led to the exclusion of older people from recent U.S. aspirin...
by editor | Sep 16, 2015 | Clinicians, Participants, Researchers
Leading US health authority releases aspirin recommendations to prevent cardiovascular disease and cancer in middle-aged The US Preventive Services Task Force (USPSTF) yesterday proposed that aspirin should be taken by people to prevent cardiovascular disease...
by editor | Aug 7, 2014 | Clinicians, Participants, Researchers
Lack of data underscores importance of ASPREE trial A large scientific review revealed that aspirin protected people aged 50-65 against gastrointestinal cancer, but was unable to determine cancer benefits for those aged over 70. International researchers, who analysed...
by editor | May 30, 2014 | Participants
High quality data answers important questions Principal Investigator to the Australian arm of the ASPREE trial, Professor John McNeil says health authorities require a high level of evidence about the balance of benefits and risks of aspirin in healthy people...
by editor | Mar 7, 2014 | Clinicians, Participants
ASPREE PI editorial in this week’s ‘Medical Observer’ ASPREE Principal Investigator in Australia, Professor John McNeil discusses what the findings of ASPREE trial may mean to future health care. “Currently, it is not known if low-grade inflammation is...
Recent Comments